![James L. Vincent](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
James L.
Vincent worked as the Chairman & CEO of Biogen, Inc. from 1985 to 1997.
He also worked as a Director at Alnylam Pharmaceuticals, Inc. from 2005 to 2010.
Additionally, he served as a Trustee at Duke University.
Anciens postes connus de James L. Vincent
| Sociétés | Poste | Fin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 22/09/2010 |
| BIOGEN INC. | Directeur Général | 01/01/1997 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
